Answer
Brinsupri is indicated to treat non-cystic fibrosis bronchiectasis in patients aged 12 years and older who have had two or more exacerbations in the previous 12 months.
Sources for this answer
- Brinsupri 25 mg film-coated tabletsInsmed Limited · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked